GB202107409D0 - Compounds for the treatment of brain cancer - Google Patents

Compounds for the treatment of brain cancer

Info

Publication number
GB202107409D0
GB202107409D0 GBGB2107409.1A GB202107409A GB202107409D0 GB 202107409 D0 GB202107409 D0 GB 202107409D0 GB 202107409 A GB202107409 A GB 202107409A GB 202107409 D0 GB202107409 D0 GB 202107409D0
Authority
GB
United Kingdom
Prior art keywords
compounds
treatment
brain cancer
brain
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2107409.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Bio Ltd
Original Assignee
BenevolentAI Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BenevolentAI Bio Ltd filed Critical BenevolentAI Bio Ltd
Priority to GBGB2107409.1A priority Critical patent/GB202107409D0/en
Publication of GB202107409D0 publication Critical patent/GB202107409D0/en
Ceased legal-status Critical Current

Links

GBGB2107409.1A 2021-05-25 2021-05-25 Compounds for the treatment of brain cancer Ceased GB202107409D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2107409.1A GB202107409D0 (en) 2021-05-25 2021-05-25 Compounds for the treatment of brain cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2107409.1A GB202107409D0 (en) 2021-05-25 2021-05-25 Compounds for the treatment of brain cancer

Publications (1)

Publication Number Publication Date
GB202107409D0 true GB202107409D0 (en) 2021-07-07

Family

ID=76637700

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2107409.1A Ceased GB202107409D0 (en) 2021-05-25 2021-05-25 Compounds for the treatment of brain cancer

Country Status (1)

Country Link
GB (1) GB202107409D0 (en)

Similar Documents

Publication Publication Date Title
EP3781564A4 (en) Compounds for the treatment of cancer
EP3781564C0 (en) Pyridazine derivatives for the treatment of cancer
EP3534923A4 (en) Combination therapy for treatment of brain cancers
IL280337A (en) Lag-3 combination therapy for the treatment of cancer
ZA202206743B (en) Therapy for the treatment of cancer
IL276482A (en) Compounds for the treatment of pain
SG11202108636SA (en) Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer
IL281845A (en) Combination therapy for the treatment of cancer
EP4010081A4 (en) Combination therapy for treatment of cancer
IL312171A (en) Novel use of quinazolinone compound for the treatment of cancer
IL284162A (en) Combination therapy for the treatment of cancer
IL304595A (en) Bicyclic tetrahydroazepine derivatives for the treatment of cancer
IL307964A (en) Combination therapy for cancer treatment
EP3454860A4 (en) 2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers
GB201800736D0 (en) Combination therapy for treatment of leukemia
EP3947460A4 (en) Multispecific agents for treatment of cancer
IL289201A (en) Compounds for treatment of cancer
EP3793548A4 (en) Compounds for treatment of pancreatic cancer
IL307465A (en) Combination therapies for the treatment of cancer
EP3565561A4 (en) Phosphaplatin compounds as therapeutic agents for treatment of bone blood cancers
GB202107409D0 (en) Compounds for the treatment of brain cancer
SG11202100571TA (en) Anti-lypd3 car t-cell therapy for the treatment of cancer
PL3630754T3 (en) Isoindoline-acetylene compounds for the treatment of cancer
IL305780A (en) Methods for the treatment of cancer
IL307338A (en) Pyridinyl substituted oxoisoindoline compounds for the treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)